Blood Diseases: West Midlands
(asked on 28th March 2018) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the take-up rate for sickle cell disease and thalassaemia screening for pregnant women in (a) the West Midlands and (b) Coventry was in 2017.
Screening for sickle cell and thalassaemia are carried out jointly as a blood test. The programme identifies people who are genetic carriers for sickle cell, thalassaemia and other haemoglobin disorders.
Between 1 April 2016 and 31 March 2017 Coventry and Warwickshire NHS Trusts had 5,925 women tested out of 5,989 eligible women (98.9% uptake).
Between 1 April 2016 and 31 March 2017 the West Midlands had 57,578 women tested out of 58,093 eligible women (99.1% uptake).
During 2016/17 the national average for screening uptake in England was 99.3%.
Further information is available at:
NHS England is responsible for commissioning antenatal screening services to meet programme standards including coverage. NHS England is working with providers to help identify and address any issues and is committed to improving coverage and reducing morbidity from this condition.